Medical Diagnostic Lab has been awarded US Patent No. 8,030,032, "Methods and compositions related thereto for detecting and identifying distinct species of nucleic acids from causative agents."
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – EraGen Biosciences today announced the US Food and Drug Administration has cleared its MultiCode-RTx HSV 1&2 kit for use on bioMérieux's NucliSens easyMag extraction system.
Akonni will use the grant to develop a closed amplicon RT-PCR microarray for detecting enterovirus, herpes viruses, and West Nile virus in cerebral spinal fluid.
In addition, Argene will provide BioMérieux with a portfolio of molecular tests for diagnosing infectious diseases in transplant and other immunocompromised patients.
According to BD, the BD ProbeTec Herpes Simplex Viruses Qx Amplified DNA Assays are the first automated molecular assays for the detection and differentiation of HSV types 1 and 2 in clinician-collected external anogenital specimens.
GenturaDx has developed a molecular diagnostic system that combines sample preparation and real-time PCR testing on a disposable cartridge in an effort to bring molecular testing to more laboratories at small- and medium-sized hospitals.
Focus and 3M are also developing a version of the influenza A/B/RSV test, as well as a test for herpes simplex virus, that would be suitable for use in moderate-complexity laboratories under the Clinical Laboratory Improvement Amendments act.
Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.
